WallStSmart

Nutex Health Inc (NUTX)vsTenet Healthcare Corporation (THC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Tenet Healthcare Corporation generates 2338% more annual revenue ($21.45B vs $879.95M). NUTX leads profitability with a 11.0% profit margin vs 7.9%. THC trades at a lower P/E of 9.1x. THC earns a higher WallStSmart Score of 66/100 (B-).

NUTX

Buy

64

out of 100

Grade: C+

Growth: 8.0Profit: 9.0Value: 8.3Quality: 7.0
Piotroski: 4/9Altman Z: 2.49

THC

Strong Buy

66

out of 100

Grade: B-

Growth: 6.0Profit: 7.0Value: 5.7Quality: 4.5
Piotroski: 4/9Altman Z: 1.73
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

NUTXUndervalued (+63.6%)

Margin of Safety

+63.6%

Fair Value

$283.22

Current Price

$135.10

$148.12 discount

UndervaluedFair: $283.22Overvalued

Intrinsic value data unavailable for THC.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

NUTX5 strengths · Avg: 9.4/10
P/E RatioValuation
9.9x10/10

Attractively priced relative to earnings

Operating MarginProfitability
37.5%10/10

Strong operational efficiency at 37.5%

EPS GrowthGrowth
95.9%10/10

Earnings expanding 95.9% YoY

Return on EquityProfitability
27.8%9/10

Every $100 of equity generates 28 in profit

Price/BookValuation
2.7x8/10

Reasonable price relative to book value

THC4 strengths · Avg: 9.5/10
P/E RatioValuation
9.1x10/10

Attractively priced relative to earnings

Return on EquityProfitability
35.4%10/10

Every $100 of equity generates 35 in profit

EPS GrowthGrowth
87.6%10/10

Earnings expanding 87.6% YoY

Free Cash FlowQuality
$1.46B8/10

Generating 1.5B in free cash flow

Areas to Watch

NUTX3 concerns · Avg: 3.3/10
Revenue GrowthGrowth
2.2%4/10

2.2% revenue growth

Market CapQuality
$927.61M3/10

Smaller company, higher risk/reward

Debt/EquityHealth
1.013/10

Elevated debt levels

THC4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
2.8%4/10

2.8% revenue growth

Altman Z-ScoreHealth
1.734/10

Distress zone — elevated risk

Profit MarginProfitability
7.9%3/10

7.9% margin — thin

PEG RatioValuation
4.312/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : NUTX

The strongest argument for NUTX centers on P/E Ratio, Operating Margin, EPS Growth.

Bull Case : THC

The strongest argument for THC centers on P/E Ratio, Return on Equity, EPS Growth.

Bear Case : NUTX

The primary concerns for NUTX are Revenue Growth, Market Cap, Debt/Equity.

Bear Case : THC

The primary concerns for THC are Revenue Growth, Altman Z-Score, Profit Margin. Debt-to-equity of 2.74 is elevated, increasing financial risk.

Key Dynamics to Monitor

NUTX carries more volatility with a beta of 2.06 — expect wider price swings.

THC is growing revenue faster at 2.8% — sustainability is the question.

THC generates stronger free cash flow (1.5B), providing more financial flexibility.

Monitor MEDICAL CARE FACILITIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

THC scores higher overall (66/100 vs 64/100). NUTX offers better value entry with a 63.6% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Nutex Health Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Nutex Health, Inc. is a technology-based healthcare services company. The company is headquartered in Houston, Texas.

Tenet Healthcare Corporation

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Tenet Healthcare Corporation is a diversified health services company. The company is headquartered in Dallas, Texas.

Want to dig deeper into these stocks?